Sam is an attorney in our Life Sciences and Chemistry group and his practice focuses on biopharmaceutics, gene editing, medical devices and synthetic biology. In addition to handling the drafting and prosecution of European patent applications, Sam has experience in coordinating prosecution of large global patent families and advising on infringement risk.
He has a particular interest in fields where the life sciences intersect with other fields and advises clients active in areas such as diagnostic devices, 3D printing and synthetic biology. Sam’s practice also extends beyond the life sciences into consumer goods.
Sam graduated with a BSc. (Hons) in biochemistry from the University of Manchester in 2014. Following his undergraduate degree Sam completed a PhD in structural biology at the Manchester Institute for Biotechnology. His research focused on understanding the structure-function relationship of novel enzymes with potential uses in the production of biofuels and bioplastics.